Equities

Eastwood Bio-Medical Canada Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
EBM:CVE

Eastwood Bio-Medical Canada Inc

Actions
  • Price (CAD)0.80
  • Today's Change-0.18 / -18.37%
  • Shares traded2.90k
  • 1 Year change+77.78%
  • Beta0.1631
Data delayed at least 15 minutes, as of Feb 12 2026 20:17 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Eastwood Bio-Medical Canada Inc. is a Canada-based company, which is engaged in marketing and distributing natural health products in North America. The Company is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The Company's Eleotin products include natural remedies for certain metabolic disorders, such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. Eleotin Bentley is used to promote healthy glucose levels while Eleotin LBM is recommended for hypertension relief. It manufactures and allocates resources towards the research and development of products.

  • Revenue in CAD (TTM)594.57k
  • Net income in CAD-411.84k
  • Incorporated2010
  • Employees--
  • Location
    Eastwood Bio-Medical Canada Inc1130 - 4871 Shell RoadRICHMOND V6X 3Z6CanadaCAN
  • Phone+1 (604) 247-2100
  • Fax+1 (604) 247-2101
  • Websitehttps://eleotin.ca/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Simply Solventless Concentrates Ltd30.71m4.17m18.51m192.008.790.56053.080.58440.01760.01760.26430.27650.7251.117.89159,949.409.84--13.15--28.99--13.57--0.7405-0.59810.3241--120.93---599.34------
Voyageur Pharmaceuticals Ltd11.04k-3.13m26.79m----17.93--2,351.27-0.0197-0.01970.000070.00810.00370.170.1428---103.95-78.90-250.45-135.25-25.63---28,307.25--0.5081--0.027-------21.99---1.10--
Decibel Cannabis Company Inc109.31m12.32m57.80m--3.600.86192.830.50270.02640.0250.1980.11020.7952.156.51--8.96-0.040113.94-0.059521.9820.0311.27-0.06880.6086-5.570.4186---12.8971.51810.61---4.74--
Arch Biopartners Inc275.95k-1.55m62.36m--------235.85-0.0237-0.02370.0042-0.05870.5306--0.7616---298.56-195.50---------562.69-123.23---3.99-----87.0032.3760.39------
LSL Pharma Group Inc26.80m2.78m63.48m--20.822.3912.622.370.0240.0240.23070.20940.54621.985.78--5.65--7.29--29.73--10.35--0.53660.65210.5325--76.98--139.15------
Eastwood Bio-Medical Canada Inc594.57k-411.84k67.51m--------92.69-0.006-0.0060.0086-0.02252.17--26.00---150.26-71.29----63.9156.40-69.27-57.09---31.24-----19.11-11.5016.60------
Medexus Pharmaceuticals Inc135.30m-370.11k91.26m91.00--1.256.930.6582-0.0142-0.01424.242.200.66081.407.681,486,812.00-0.1808-3.71-0.3159-6.2253.8752.71-0.2736-5.740.61971.230.3268---4.1814.311,150.00--24.90--
Data as of Feb 12 2026. Currency figures normalised to Eastwood Bio-Medical Canada Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.